(Q40920163)

24 September 2017

1 reference

title

Immunostimulating agents: what next? A review of their present and potential medical applications (English)

1 reference

24 September 2017

G H Werner

1

1 reference

24 September 2017

P Jollès

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

24 September 2017

1 reference

24 September 2017

volume

242

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

1-19

1 reference

Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Therapeutic potential of cytokine manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

The neglected organ: bacterial flora has a crucial immunostimulatory role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Development of the cytokine inducer romurtide: experimental studies and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

A short lipopeptide, representative of a new family of immunological adjuvants devoid of sugar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Immunopotentiating activities of a low molecular weight lipopeptide, RP 56 142--studies in infectious models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Enhancing effects of immunoactive peptide FR48217 on immunological responses to vaccination by inactivated influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Casein: a milk protein with diverse biologic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Vitamin A Status: Relationship to Immunity and the Antibody Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Ethanol, immune responses, and murine AIDS: the role of vitamin E as an immunostimulant and antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Enoxacin therapy for experimental pseudomonas keratitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Adjuvants: current status, clinical perspectives and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Molecular adjuvants and immunomodulators: new approaches to immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Adjuvants for human vaccines--current status, problems and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Immunoadjuvant activity of a liposomal IL-6 formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-1033.1996.0001R.X

10.1111/J.1432-1033.1996.0001R.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference